Kennedy researchers have uncovered key design parameters for bispecific T-cell engagers (TcEs)—a class of cancer ...

Analysis revealed that patients with T-cell exhausted archetype tumors had significantly higher rates of progressive disease ...

Instead of extracting T-cells and engineering them in a lab, researchers have delivered mRNA directly into circulating immune ...

In the largest study of its kind, researchers from The University of Texas MD Anderson Cancer Center identified three ...

T cells are a promising cancer therapy that are made from the patient's own T cells, which are reprogrammed to fight their ...

Bengaluru: In a landmark development for cancer care in India and for Chimeric Antigen Receptor T-cell (CAR T) therapy, two ...

Researchers have developed new CAR-T cells to target malignant tumors. Their method targeted a protein found in high amounts ...

Dubai, United Arab Emirates — Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, may be ...

Chimeric antigen receptor (CAR)-T cells are a promising cancer therapy that are made from the patient's own T cells, which ...

Glioblastoma has been deadly and hard to treat, but researchers say they’ve made progress with bivalent CAR T-cell therapy ...

The blood cancer multiple myeloma is deadly. This disease is personal for us because one of our best friends and colleagues died from the complications of this malignancy in 2006.